a subscriber who prefers to remain unnamed [edited]Re: ProMED-mail post Syphilis - Canada: (MB) increased incidence, Bicillin shortage 20160501.4195457----------------------------------------------------------------------------------------------------[The following is reprinted from the CDC website: <http://www.cdc.gov/std/treatment/drugnotices/bicillinshortage.htm>.]""CDC was recently notified of difficulties in obtaining Bicillin-LA (benzathine penicillin G). Benzathine penicillin G is the recommended treatment for syphilis and the only treatment option for pregnant women infected with or exposed to syphilis. The recommended treatments for syphilis are outlined in the 2015 STD Treatment Guidelines <http://www.cdc.gov/std/tg2015/syphilis.htm> along with alternative regimens. For more information regarding the availability of Bicillin-LA, visit the FDA Drug Shortage website <http://1.usa.gov/1NTaVrc>and American Society of Health System Pharmacists Drug Shortage website <http://www.ashp.org/menu/DrugShortages/CurrentShortages/Bulletin.aspx?id=1232>.""""Drug shortages can be reported at <http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm142398.htm>. Until normal supplies of Bicillin-LA are available, consideration should be given to prioritizing the use of Bicillin-LA for the treatment of syphilis especially in pregnant women infected with or exposed to syphilis.""--Communicated by:ProMED-mail<promed@promedmail.org>[ProMED-mail thanks the submitter for drawing our attention to the CDC website concerning the Bicillin-LA shortage. - Mod.MLA HealthMap/ProMED-mail map can be accessed at: <http://healthmap.org/promed/p/106>.]
